Filed Pursuant to Rule 433
Registration No. 333-185213
Free Writing Prospectus dated May 1, 2014
Hyundai Auto Receivables Trust 2014-B
Issuing Entity
| Hyundai ABS Funding Corporation | Hyundai Capital America |
| Depositor | Sponsor, Seller, Administrator and Servicer |
The depositor has prepared a preliminary prospectus supplement dated May 1, 2014 and prospectus May 1, 2014, which describe the notes to be issued by the issuing entity. You should review the prospectus supplement and the prospectus in their entirety before deciding to purchase any of the notes.
Ratings
The depositor expects that the notes issued by the issuing entity will receive the indicated ratings from the nationally recognized statistical rating organizations, or “rating agencies,” listed below.
Fitch Ratings, | Standard & | |
| Class A-1 notes | F1+sf | A-1+ (sf) |
| Class A-2 notes | AAAsf | AAA (sf) |
| Class A-3 notes | AAAsf | AAA (sf) |
| Class A-4 notes | AAAsf | AAA (sf) |
| Class B notes | AAsf | AA+ (sf) |
| Class C notes | Asf | AA- (sf) |
| Class D notes | BBBsf | BBB+ (sf) |
It is a condition to the issuance of the notes that each class of the notes receive at least the ratings listed above.
Joint Bookrunners of the Class A, B, C and D Notes
| ||||||||||||
| J.P. Morgan | BNP PARIBAS | HSBC | RBC Capital Markets | |||||||||
| Co-Managers of the Class A Notes | ||||||||||||
| ● | ● | ● | ● | ● | ||||||||
The depositor has filed a registration statement (including a prospectus supplement and prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus supplement and the prospectus in that registration statement and other documents the depositor has filed with the SEC for more complete information about the depositor, the issuing entity and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the depositor, any underwriter or any dealer participating in the offering will arrange to send you the prospectus supplement and prospectus if you request it by calling 1-866-669-7629.